Effects of genistein, apigenin, quercetin, rutin and astilbin on serum uric acid levels and xanthine oxidase activities in normal and hyperuricemic mice

Food and Chemical Toxicology

Volumn 49, Issue 9, 2011, Pages 1943-1947

  Huang, Jingqun ^a   Wang, Siwang ^a   Zhu, Miaozhang ^a   Chen, Jianzong ^b   Zhu, Xiaoxing ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apigenin; Astilbin; Genistein; Quercetin; Rutin; Xanthine oxidase

Indexed keywords

ALLOPURINOL; APIGENIN; ASTILBIN; CREATININE; GENISTEIN; NITROGEN; QUERCETIN; RUTOSIDE; UREA; URIC ACID; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HYPERURICEMIA; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FUNCTION; MALE; MOUSE; NONHUMAN; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ANIMALS; APIGENIN; FLAVONOIDS; FLAVONOLS; GENISTEIN; HYPERURICEMIA; MICE; QUERCETIN; RUTIN; URIC ACID; XANTHINE OXIDASE;

MUS;

EID: 79960838729     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.04.029     Document Type: Article

References (25)

1. Battelli M.G., Abbondanza A., Musiani S., Buonamici L., Strocchi P., Tazzari P.L., Gramantieri L., Stirpe F. Determination of xanthine oxidase in human serum by a competitive enzyme-linked immunosorbent assay (ELISA). Clin. Chim. Acta. 1999, 281:147-158.
2. Carroll J.J., Roberta Douglass H.C., Badson A.L. A simplified alkaline phosphotungstate assay for uric acid in serum. Clin. Chem. 1971, 17:158-160.
3. Choi H.K., Ford E.S. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am. J. Med. 2007, 120:442-447.
4. Finco D.R., Duncan J.R. Evaluation of blood urea nitrogen and serum creatin concentrations as indicators of renal dysfunction: a study of 111 cases and a review of related literature. J. Am. Vet. Med. Assoc. 1976, 168:593-601.
5. Hall I.H., Scoville J.P., Reynolds D.J., Simlot R., Duncan P. Substituted cyclic imides as potential anti-gout agents. Life Sci. 1990, 46:1923-1927.
6. Heinig M., Johnson R.J. Role of uric acid in hypertension, renal disease, and metabolic syndrome. Cleve. Clin. J. Med. 2006, 73:1059-1064.
7. Kong L.D., Yang C., Ge F., Wang H.D., Guo Y.S. A Chinese herbal medicine Ermiao wan reduces serum uric acid level and inhibits liver xanthine dehydrogenase and xanthine oxidase in mice. J. Ethnopharmacol. 2004, 93:325-330.
8. Lin C.M., Chen C.S., Chen C.T., Liang Y.C., Lin J.K. Molecular modeling of flavonoids that inhibits xanthine oxidase. Biochem. Biophys. Res. Commun. 2002, 294:167-172.
9. Lotito S.B., Frei B. Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon? Free. Radic. Biol. Med. 2006, 41:1727-1746.
10. Mo S.F., Zhou F., Lv Y.Z., Hu Q.H., Zhang D.M., Kong L.D. Hypouricemic action of selected flavonoids in mice: structure-activity relationships. Biol. Pharm. Bull. 2007, 30:1551-1556.
11. Murugaiyah V., Chan K.L. Mechanisms of antihyperuricemic effect of Phyllanthus niruri and its lignan constituents. J. Ethnopharmacol. 2009, 124:233-239.
12. Nishioka H., Fujii H., Sun B., Aruoma O.I. Comparative efficacy of oligonol, catechin and (-)-epigallocatechin 3-O-gallate in modulating the potassium bromate-induced renal toxicity in rats[J]. Toxicology 2006, 226:181-187.
13. Ramallo I.A., Zacchino S.A., Furlan R.L. A rapid TLC autographic method for the detection of xanthine oxidase inhibitors and superoxide scavengers. Phytochem. Anal. 2006, 17:15-19.
14. Roddy E., Zhang W., Doherty M. The changing epidemiology of gout. Nat. Clin. Pract. Rheumatol. 2007, 3:443-449.
15. Short R.A., Tuttle K.R. Clinical evidence for the influence of uric acid on hypertension, cardiovascular disease, and kidney disease: a statistical modeling perspective. Semin. Nephrol. 2005, 25:25-31.
16. Stavric B., Clayman S., Gadd R.E., Hebert D. Some in vivo effects in the rat induced by chloprothixene and potassium oxonate. Pharmacol. Res. Commun. 1995, 7:117-124.
17. Terkeltaub R.A. Clinical practice. Gout. N. Engl. J. Med. 2003, 349:1647-1655.
18. Umamaheswari M., AsokKumar K., Somasundaram A., Sivashanmugam T., Subhadradevi V., Ravi T.K. Xanthine oxidase inhibitory activity of some Indian medical plants. J. Ethnopharmacol. 2007, 109:547-551.
19. Unno T., Sugimoto A., Kakuda T. Xanthine oxidase inhibitors from the leaves of Lagerstroemia speciosa (L). Pers. J. Ethnopharmacol. 2004, 93:391-395.
20. Van Hoorn D.E., Nijveldt R.J., Van Leeuwen P.A., Hofman Z., M'Rabet L., De Bont D.B., Van Norren K. Accurate prediction of xanthine oxidase inhibition based on the structure of flavonoids. Eur. J. Pharmacol. 2002, 451:111-118.
21. Wang B., Feng W.Y., Wang T.C., Jia G., Wang M., Shi J.W., Zhang F., Zhao Y.L., Chai Z.F. Acute toxicity of nano- and micro-scale zinc powder in healthy adult mice. Toxicol. Lett. 2006, 161:115-123.
22. Wang Y., Zhu J.X., Kong L.D., Yang C., Cheng C.H., Zhang X. Administration of procyanidins from grape seeds reduces serum uric acid levels and decreases hepatic xanthine dehydrogenase/oxidase activities in oxonate-treated mice. Basic Clin. Pharmacol. Toxicol. 2004, 94:232-237.
23. Wu E.Q., Patel P.A., Yu A.P., Mody R.R., Cahill K.E., Tang J., Krishnan E. Disease-related and all-cause health care costs of elderly patients with gout. J. Manag. Care. Pharm. 2008, 14:164-175.
24. Zhao X., Zhu J.X., Mo S.F., Pan Y., Kong L.D. Effect of cassia oils on serum and hepatic uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver. J. Ethnophare. 2006, 103:357-365.
25. Zhou C.X., Kong L.D., Ye W.C., Cheng C.H.K., Tan R.X. Inhibition of xanthine and monoamine oxidases by stilbenoids from Veratrum taliense. Planta. Med. 2001, 67:158-161.